Medtronic
MDT
2,203 hedge funds and large institutions have $98.4B invested in Medtronic in 2026 Q3 according to their latest regulatory filings, with 232 funds opening new positions, 949 increasing their positions, 792 reducing their positions, and 128 closing their positions.
81% more first-time investments, than exits
New positions opened: 232 | Existing positions closed: 128
70% more funds holding in top 10
Funds holding in top 10: 23 → 39 (+16)
36% more capital inflows, than outflows
Capital inflows: $10.3B | Capital outflows: $7.52B
20% more repeat investments, than reductions
Existing positions increased: 949 | Existing positions reduced: 792
2% more funds holding
Funds holding: 2,159 → 2,203 (+44)
1.16% more ownership
Funds ownership: 86.67% → 87.83% (+1.2%)
21% less call options, than puts
Call options by funds: $2.11B | Put options by funds: $2.67B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$1.03B |
| 2 |
Aristeia Capital
Greenwich,
Connecticut
|
+$693M |
| 3 |
Millennium Management
New York
|
+$604M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$602M |
| 5 |
BlackRock
New York
|
+$419M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.51B |
| 2 |
JP Morgan Chase
New York
|
-$535M |
| 3 |
D.E. Shaw & Co
New York
|
-$317M |
| 4 |
Barclays
London,
United Kingdom
|
-$248M |
| 5 |
Renaissance Technologies
New York
|
-$201M |
MDT Hedge Fund Activity: Q3 2026 in Review
2,203 of the 8,221 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q3 2026, worth a combined $98.4B — up 12% from $88.1B a quarter earlier.
Buyers outnumbered sellers: 232 funds opened new MDT positions and 128 closed out — a net gain of 104 holders — while 949 added to existing stakes and 792 trimmed.
The largest buyer was UBS AM, adding an estimated $1.03B. The largest seller was Royal Bank of Canada, cutting an estimated $1.51B.
- 2,203 institutional investors held Medtronic (MDT) as of Q3 2026, up from 2,159 in Q2 2026.
- Funds reported $98.4B of Medtronic stock for Q3 2026, up 12% quarter-over-quarter.
- 232 funds opened new Medtronic positions in Q3 2026 and 128 closed out, a net change of +104 holders.
- The largest Medtronic buyer in Q3 2026 was UBS AM, an estimated $1.03B added.
- The largest Medtronic seller in Q3 2026 was Royal Bank of Canada, an estimated $1.51B sold.
Based on aggregated 13F filings for Q3 2026.